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Summary
 
A recent crystal structure of the N15 
 
a/b
 
-T cell receptor (TCR) in complex with an Fab de-
rived from the H57 C
 
b
 
-specific monoclonal antibody (mAb) shows the mAb fragment inter-
acting with the elongated FG loop of the C
 
b
 
 domain. This loop creates one side wall of a cav-
ity within the TCR Ti-
 
a/b
 
 constant region module (C
 
a
 
C
 
b
 
) while the CD and EF loops of
the C
 
a
 
 domain form another wall. The cavity size is sufficient to accommodate a single non-
glycosylated Ig domain such as the CD3
 
e
 
 ectodomain. By using specific mAbs to mouse TCR-
 
b
 
(H57) and CD3
 
e
 
 (2C11) subunits, we herein provide evidence that only one of the two CD3
 
e
 
chains within the TCR complex is located in close proximity to the TCR C
 
b
 
 FG loop, in
support of the above notion. Moreover, analysis of T cells isolated from transgenic mice ex-
pressing both human and mouse CD3
 
e
 
 genes shows that the heterologous human CD3
 
e
 
 com-
ponent can replace the mouse CD3
 
e
 
 at this site. The location of one CD3
 
e
 
 subunit within the
rigid constant domain module has implications for the mechanism of signal transduction
throughout T cell development.
 
E
 
ach TCR consists of a clonotypic TCR heterodimer
(Ti-
 
a/b
 
 or Ti-
 
g/d
 
 subunits) in complex with the in-
variant CD3 chains (
 
g
 
, 
 
d
 
, 
 
e
 
, and 
 
z
 
). The disulfide-linked
heterodimer represents the peptide–MHC ligand binding
unit, thereby determining the ligand specificity of an indi-
vidual T cell. In contrast, the CD3 polypeptides which are
in noncovalent association with a given Ti heterodimer,
mediate TCR-base signal transduction (for review see ref-
erences 1–5). Although CD3-
 
g
 
 and -
 
d
 
 are present in only
one copy each (6–8), it appears that two copies of CD3
 
e
 
and 
 
z
 
 exist per TCR complex (9–11). The signaling func-
tion of the CD3 components involves a conserved motif,
termed an immunoreceptor tyrosine-based activation motif
(ITAM) present in one to three copies in the cytoplasmic
domain of each CD3 subunit (12, 13). The various CD3
subunits exhibit different interactions with intracellular sig-
naling factors and induce distinct patterns of cellular protein
tyrosine phosphorylation upon activation (14–19). How
peptide–MHC ligand binding to a Ti-
 
a/b
 
 or Ti-
 
g/d
 
 het-
erodimer subsequently initiates signaling via the CD3 mol-
ecules is currently unknown.
Aside from their role in signal transduction, the CD3
subunits are also required for cell surface expression of the
TCR heterodimers on mature T lymphocytes (20, 21), as
well as for pre-T cell receptor function on immature
CD4
 
2
 
CD8
 
2
 
 double negative (DN)
 
1
 
 thymocytes (22, 23).
Thus, without CD3
 
e
 
 or -
 
z
 
 subunit expression there is a
marked decrease or absence of TCR molecules on the cell
surface as shown by in vitro analysis (20, 21, 24). In addi-
tion, in genetically engineered mouse strains in which these
CD3 components are deleted by homologous recombina-
tion, there is a developmental blockade of thymocytes at
the DN stage (25–29). The CD3
 
d
 
 subunit, in contrast to
CD3
 
e
 
 and -
 
z
 
 chains, is required for TCR expression only
at a later stage of thymic development. The absence of
CD3
 
d
 
 in a knockout mouse specifically blocks the thymic
selection processes mediating the transition from double
positive (DP) (CD4
 
1
 
CD8
 
1
 
) to single positive (CD4
 
1
 
CD8
 
2
 
or CD4
 
2
 
CD8
 
1
 
) thymocytes (30).
Although the overall stoichiometry of the TCR com-
plex is commonly given as TCR-
 
a/b
 
–CD3
 
g/d/e
 
2
 
/z
 
2
 
, there
is no direct structural evidence to support this subunit
composition. Recently, a three-dimensional structure of
the N15 vesicular stomatitis virus–specific/H-2K
 
b
 
-restricted
 
a/b
 
-TCR (31) in complex with an Fab fragment from the
 
1
 
Abbreviations used in this paper:
 
 DN, double negative; DP, double positive;
mFI, mean fluorescence intensity; pT
 
a
 
, pre-T
 
a
 
; tg, transgenic; WT,
wild-type.
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H57 anti–mouse C
 
b
 
-specific mAb (32) provided a clue
with which to infer new details about the association be-
tween the TCR-
 
a/b
 
 heterodimer and CD3
 
e
 
 (33). We
identified a cavity within the TCR-
 
a
 
/
 
b
 
 C module formed
by the C
 
b
 
 FG loop, partially exposed C
 
b
 
 domain strands,
and conserved glycans from both C
 
a
 
 and C
 
b
 
 domains that
can accommodate a single Ig-like domain. Based on size
and charge considerations, we suggested that the cavity
probably represents the CD3
 
e
 
 binding site. To determine
whether there is a physical proximity between the C
 
b
 
 FG
loop and the CD3
 
e
 
 chain, we performed a set of competi-
tion assays between the H57 and the CD3
 
e
 
-specific 2C11
mAbs (34). The results of these experiments provide evi-
dence that one of the two CD3
 
e
 
 subunits in a TCR com-
plex is physically adjacent to the TCR-
 
b
 
 constant region
FG loop.
 
Materials and Methods
 
Transgenic Mice.
 
Transgenic mice expressing the human CD3
 
e
 
gene (transgenic [tg] 600; reference 35) were provided by Dr.
Cox Terhorst (Beth Israel Medical Center, Boston, MA) and are
further referred to as hCD3
 
e
 
tg. This transgenic mouse strain con-
tains 10–12 copies of the human CD3
 
e
 
 transgene in a hemizy-
gous mouse. Since T cell development is blocked in the
homozygous mice of this strain, we used hCD3
 
e
 
tg heterozygous
mice for these studies. A littermate that does not contain the hu-
man CD3
 
e
 
 transgene was used as a control (wild-type, WT).
 
Molecular Modeling of the N15 TCR-H57 Fab Complex.
 
The mo-
lecular modeling was produced using the N15 TCR and H57 Fab
complex crystal structure 3D coordinates (PDB code 1NFD; 33).
The plot of the protein structure was created using the programs
MOLSCRIPT (36) and RASTER3D (37).
 
Flow Cytometric Analysis.
 
The following mAbs were used:
R-PE-labeled anti–mouse CD3
 
e
 
 (500A2; PharMingen, San Di-
ego, CA), PE-labeled anti–mouse CD4 (H129.19; GIBCO BRL,
Gaithersburg, MD), and Red613-labeled anti–mouse CD8 (53-
6.7; GIBCO BRL). The mAbs hamster anti–mouse TCR-
 
b
 
(H57-597; reference 32), hamster anti–mouse CD3
 
e
 
 (2C11-145;
reference 34), and mouse anti–mouse V
 
b
 
8.1,2,3 (F23.1; refer-
ence 38) were purified and labeled with FITC using the FluoRe-
porter
 
Ò
 
 FITC protein-labeling kit (Molecular Probes, Eugene,
OR). Generation and purification of 2C11 and H57 Fab frag-
ments were performed by using the ImmunoPure Fab Prepara-
tion Kit (Pierce, Rockford, IL). The purity of the Fab fragments
was confirmed by SDS-PAGE, which demonstrated no residual
intact IgG. Splenocytes from nontransgenic mice (WT) or mice
heterozygous for human CD3
 
e
 
 (hCD3
 
e
 
tg) were triple stained as
follows: cells were incubated with PE-labeled anti-CD4, Red613-
labeled anti-CD8, and FITC-H57 or FITC-2C11 for 30 min at
4
 
8
 
C in PBS containing 2% FCS. For mAb competition assays,
splenocytes were first incubated with unlabeled H57 or 2C11
mAbs at 10-fold molar excess of the FITC-labeled mAb for 30 min
at 4
 
8
 
C, washed with PBS 
 
1 
 
2% FCS, and triple stained as ex-
plained above. Flow cytometric analysis was performed on a
FACScan (Becton Dickinson, San Jose, CA). Samples were gated
on live cells based on forward and side scatter parameters. Data
(10,000 events per sample) were collected in list mode using
FACScan Research software and analyzed using LYSYS II
 
 
 
soft-
ware (Becton Dickinson). The mean fluorescence intensity (mFI)
of the FITC-labeled H57 or FITC-labeled 2C11 labeled T cells
(CD4
 
1
 
 or CD8
 
1
 
 splenocytes) was measured and the FITC mFI
of non-T cell splenocytes (CD4
 
2
 
 or CD8
 
2
 
; background) was de-
ducted from this value in each sample.
 
Results
 
A TCR Constant Domain Module Cavity as a Putative
CD3
 
e
 
 Binding Site.
 
The three-dimensional structure of a
complex between the N15 
 
a/b
 
-TCR and the anti–TCR-
 
b
 
chain mAb H57 Fab fragment resolved crystallographically
to 2.8Å has revealed several interesting features about TCR
structure relative to antibody structure. As shown in Fig. 1,
there is an obvious difference between the ligand binding
surface of the V domain modules of the two receptors
(V
 
a
 
V
 
b
 
 versus V
 
h
 
V
 
l
 
), with a relatively flat antigen binding
surface in the case of the TCR, versus a concave surface in
the case of the Fab. The flatness of the N15 antigen bind-
ing surface and the concavity of the H57 Fab surface are
complementary to the surface of their respective ligands, K
 
b
 
and C
 
b
 
. Perhaps the most striking difference between these
immunoreceptors is the symmetry of the Fab molecule
compared with asymmetry of the TCR molecule. This
TCR asymmetry results from the unusual arrangement of
the C
 
a
 
 and C
 
b
 
 domains relative to one another. More-
over, as shown in Fig. 1, the H57 Fab binds to the 12-resi-
due C
 
b
 
 FG loop conserved among TCR C
 
b
 
 domains
from multiple species (39). This loop architecture is
uniquely rigidified by a hydrophobic minicore and an in-
ternal hydrogen bonding network. In addition, we have
noted that this loop creates one side wall of a cavity, while
the CD and EF loops of the Ca domain form the other
side. The floor of the cave, which measures z25Å in
depth,  z20Å in height, and z25Å in width, is presumably
formed by the plasma membrane on the T cell surface. The
murine CD3e subunit, which is predicted to have an Ig
fold (40), is nonglycosylated unlike CD3g and CD3d, and
could readily fit into a cavity of this size.
Nonreciprocal Cross-blocking of 2C11 and H57 mAbs. To in-
vestigate our hypothesis that a CD3e subunit might occupy
this cavity within the C module and hence lie proximal to
the Cb FG loop, a set of competition assays between the H57
and 2C11 mAbs were performed using direct immunofluo-
rescence analysis by FACSÒ. 2C11 was previously shown
to specifically bind to the mouse CD3e subunit (34). As
shown in Fig. 2 A, unlabeled competitor 2C11 or H57 was
added before the addition of FITC-2C11, FITC-H57, or
FITC-labeled anti-CD4, and log fluorescence was deter-
mined by quantitative FACSÒ analysis. As expected, unla-
beled 2C11 blocks the subsequent binding of FITC-2C11
and, likewise, unlabeled H57 blocks the binding of FITC-
H57. In contrast, neither unlabeled 2C11 nor H57 alters
the binding of the unrelated FITC-H129.19. More impor-
tantly, note that under these conditions the anti-CD3e
mAb completely blocks the binding of FITC-H57 mAb,
whereas H57 only partially reduces the mFI of FITC-2C11
binding to CD3e on mouse splenic T cells. A second anti-
CD3e mAb, 500A2, also completely blocked FITC-H571531 Ghendler et al.
binding and, as with FITC-2C11, the binding of PE-
500A2 was reduced by 50% when T cells were preincu-
bated with unlabeled H57 (data not shown). Moreover,
similar results were obtained by using 2C11 Fab or H57
Fab fragments for inhibition analysis. That the findings are
not secondary to “general” steric blockade of the TCR by
any mAb or Fab fragment binding to the complex is evi-
dent from the inability of Vb-specific antibodies to block
FITC-H57 binding on TCR transgenic T lymphocytes
(data not shown).
Only One of the Two CD3e Subunits Is Proximal to the Cb
FG Loop. To quantify the mFI reduction in FITC-2C11
resulting from unlabeled H57 preincubation in individual
CD4 and CD8 T cell subsets, we performed the analogous
competition experiments by three-color analysis, in addi-
tion using PE-labeled anti–mouse CD4 and Red613-labeled
anti–mouse CD8. We collected data comparable to that
shown in Fig. 2 A but on individual splenic CD41 and CD81
T lymphocytes. As shown in Fig. 2 B (left) for CD41 T
cells, although unlabeled 2C11 completely blocked the
binding of FITC-2C11 to the mouse T cells, the unlabeled
H57 mAb reduced the binding of the FITC-2C11 by
z50% (mFI, from 402 to 183). On the other hand, unla-
beled 2C11 almost completely blocked the binding of FITC-
H57 (mFI, from 398 to 45; Fig. 2 B, right). Identical results
were obtained when CD81 T cells subset were examined.
Three conclusions may be drawn from these data. First,
one CD3e subunit is close to the H57 mAb binding site on
the Cb FG loop. Second, given that there are two CD3e
components per TCR (10, 11) and the H57 mAb can only
block 50% of the FITC-2C11 binding, the second CD3e
subunit must exist at a distance from the Cb FG loop.
Third, this postulated TCR subunit arrangement is found
in both CD41 and CD81 T cell subpopulations.
The Human CD3e Subunit as well as the Mouse CD3e Sub-
unit Associates with the CaCb Module. To test whether re-
placement of the murine CD3e chain with the human
CD3e subunit might alter the binding affinity of the H57
mAb to the Cb FG epitope, we used a well-characterized
transgenic mouse strain (tg 600) engineered to express the
human CD3e component (reference 35; here referred to as
hCD3etg). Splenocytes from littermates that do not express
the human CD3e (WT), as well as a heterozygous hCD3etg
mouse, were stained with directly labeled FITC-2C11
mAb at concentrations ranging from 5 3 1026–10210 M.
As shown in Fig. 3 A, the hCD3etg mouse expressed only
Figure 1. Model of the N15 a/b-TCR heterodimer complexed with the H57 anti-TCR Cb-specific mAb Fab fragment. Based on x ray coordinates
and molecular modeling as described in Materials and Methods, a structure of the complex is shown. The TCR-a chain is in green, the TCR-b chain is
in red, the H57 Fab heavy chain is in gold, and H57 Fab light chain is in purple. The Cb FG loop, which is the epitope recognized by the mAb H57, is
indicated. This loop creates one side wall of a cavity (whose center is marked by the Cb label) within the TCR Ti a/b constant region while the CD (*)
and EF (**) loops of the Ca domain form the other side. The cavity size is sufficient to accommodate a single nonglycosylated Ig domain such as the
CD3e chain.1532 T Cell Receptor Subunit Topology
z50% of the normal cell surface level of mouse CD3e.
However, 2C11 binding affinity to the mouse CD3e sub-
unit is not altered by the presence of the human CD3e
component (Kd z1028 M). The capacity of the unlabeled
2C11 mAb to block binding of FITC-H57 to heterozy-
gous hCD3etg T cells was also examined. As shown in Fig.
3  B, the same amount of unlabeled 2C11 that blocks
FITC-H57 binding to the WT mouse T cells only partially
blocks the FITC-H57 binding to hCD3etg T cells. This
suggests that the human CD3e subunit can replace the
mouse CD3e subunit in agreement with the finding of oth-
ers (10, 41), and that it can occupy the cavity within the
mouse TCR CbCa module. Fig. 3 B also demonstrates
that the incubation of the mouse splenocytes with the
2C11 mAb does not block the binding of H57 to the
TCR-b chain by downmodulation of the TCR complex
from the T cell surface (42, 43). Thus, unlabeled 2C11 pre-
incubation does not change the binding of the anti Vb8
mAb, FITC-F23.1, to T cells.
The Binding of the H57 mAb to the Cb FG Loop Is Unaf-
fected by Human Versus Mouse Origin of the CD3e Compo-
nent. In contrast to the results comparing mouse CD3e in
WT and hCD3etg mice where the level of 2C11 expres-
sion is z50% on the latter (Fig. 3 A), H57 reactivity is
equivalent in both (Fig. 4).This implies that the affinity of
H57 mAb to the Cb FG loop is not altered by the presence
of the human CD3e component. Had human CD3e al-
tered the affinity of H57, then the curves of mFI at differ-
ent molar concentrations of FITC-H57 would have shown
Figure 2. The anti-CD3e mAb (2C11) blocks the binding of the anti–
TCR-b mAb (H57). (A) Splenocytes (106 per sample) were incubated ei-
ther with no antibody or with 10 mg/ml unlabeled mAbs 2C11 or H57
for 30 min, then washed and reincubated with 1 mg/ml of the FITC-
labeled mAbs 2C11 or H57 or anti–mouse CD4 mAb. After washing, the
cells were analyzed on a FACScan as described in Materials and Methods.
Each unlabeled mAb blocks the identical FITC-labeled antibody. The
unlabeled 2C11 blocks FITC-H57 (center histogram), whereas H57 only
partially blocks the binding of FITC-2C11 to CD3e (lower left histogram).
Neither 2C11 nor H57 block the FITC-labeled anti-CD4 mAb (right col-
umn). (B) The same competition experiment was performed as described
above but after the preincubation with the unlabeled competitor mAb the
splenocytes were triple-stained with FITC-H57 or FITC-2C11 and both
PE–anti-CD4 and Red613–anti-CD8. Histograms show the FITC-H57
or FITC-2C11 staining of T cells (after gating for CD41 and CD81 cells)
in the presence or absence (Non) of the unlabeled competitor mAbs. The
mFI of each curve is indicated in parenthesis. Only CD41 data is shown.
Figure 3. Human CD3e can replace the mouse CD3e within the rigid
TCR-a/b constant domain module. (A) Splenocytes from a nontrans-
genic mouse (WT) or a mouse heterozygous for human CD3e (hCD3etg)
were triple stained with the indicated molar concentration of FITC-2C11
as well as with PE–anti-CD4 and Red613–anti-CD8. The mFI of the
FITC-2C11 labeled T cells was calculated as explained in Materials and
Methods. Note that although the hCD3etg T cells express only half of the
WT CD3e, the 2C11 binding affinity to the mouse CD3e is not altered
by the presence of the human CD3e subunit. 2C11 preincubation com-
pletely blocks FITC-2C11 binding in WT mice. (B) Splenocytes from
WT or hCD3etg mice were preincubated with no antibody or with the
unlabeled 2C11, washed and then reincubated with the FITC-labeled
mAb H57 or the anti-Vb8 (F23.1) as explained in the legend of Fig. 1.
Although the total copy number of the mouse CD3e subunits in
hCD3etg T cells is half of that in WT animals, 2C11 mAb only partially
blocks the FITC-H57 binding in the hCD3etg mouse (lower center histo-
gram). Note that preincubation of the T cells with 2C11 had no effect on
the TCR expression level since the anti-Vb8 mAb binds to a subset of T
cells expressing Vb8 as well with or without 2C11 competition (right).1533 Ghendler et al.
a difference in the two mouse strains. Unlabeled 2C11
competitor mAb shifts the binding curve by z2 logs, at
concentrations of FITC-H57 below 1026 M. At the high-
est concentration of FITC-H57 (1026 M), the labeled anti-
body binds similarly in the presence or absence of unla-
beled competitor 2C11 mAb. These finding are consistent
with the notion that the epitopes defined by H57 and
2C11 mAbs are distinct but nevertheless partially overlap-
ping.
Discussion
The crystal structure of the complex between the N15
TCR and an Fab fragment of the anti-Cb mAb H57 led us
to the hypothesis that one CD3e may physically associate
with the H57 mAb epitope on Cb (33). In this paper we
demonstrate that one of the two CD3e subunits of the
TCR lies adjacent to the Cb FG loop.
The overall shape of the TCR C domain module is re-
markably asymmetric (Fig. 1). The Cb domain bends more
acutely towards the Vb domain compared with the angle
formed between the Ca and Va domains. Cb also has an
unusually long and well-structured FG loop (the H57 mAb
epitope) projecting down from the Vb-Cb interface in all
TCRs studied to date (33, 44, 45). Although half of the Cb
domain’s ABED sheet is surface exposed, it does not make
contact with the Ca domain. As described in detail by
Wang et al. (33), this asymmetry creates a cave-like struc-
ture or cavity below the b chain sufficient in size to ac-
commodate a single Ig domain. The partially exposed
ABED  b sheet of the Cb domain forms an extensive ceil-
ing. The CD and EF loops of the Ca domain, along with
the glycans attached to CaN185, CaN121, and CbN186
form one side wall, and the FG loop of Cb and the glycan
emanating from CbN236 form the other side wall of the
cavity. The glycans project outward and do not obstruct
the cavity. The floor of the cave is presumably formed by
the plasma membrane on the T cell surface (33). It is note-
worthy that the accessible surface at the a/b-TCR cavity
contains multiple basic residues.
The murine CD3e subunit consists of 87 residues in the
extracellular segment, and has Ig-like characteristics sug-
gesting that this segment can readily fold into a small Ig do-
main (40). CD3e is the only CD3 subunit with a nonglyc-
osylated Ig-like ectodomain in the TCR complex of man
and mouse (40). Moreover, the CD3e subunit has twice as
many acidic residues as basic ones and is therefore nega-
tively charged (pI 5 4.5, whereas the predicted pIs of the
CD3g and CD3d extracellular domains are more basic, be-
ing 8.76 and 5.82, respectively). The charge complementa-
tion between the acidic residues of the CD3e subunit and
the basic cavity also argues in favor of the CD3e subunit
occupying this site. The initial hypothesis regarding the
proximity of CD3e and the Cb FG loop was confirmed
here by a set of competition assays in which the 2C11 and
H57 mAbs, which bind to epitopes on CD3e and TCR-b,
respectively, were able to alter each other’s binding capac-
ity. We further showed that although there are two CD3e
subunits per TCR-b subunit, only one of the CD3e com-
ponents is in close proximity to the Cb FG loop. Given
that the g/d-TCR includes CD3 components (46) and is
predicted to contain an equivalent insertion in the corre-
sponding constant domain loop (47) analogous to the Cb
FG loop, we can reasonably predict that a cavity with a
comparable arrangement for CD3e exists in g/d T cells.
If the TCR C module cavity associates with one CD3e,
where is the second CD3e located? In vitro translation
studies have shown that when CD3e is translated alone it
tends to form disulfide-linked oligomers. However, using
more physiological TCR-a/b–CD3 expression conditions,
namely simultaneous cotranslation of all the TCR subunits,
the cotranslation of CD3g or CD3d was sufficient to keep
CD3e in a monomeric state (48). Both CD3g and CD3d
compete for binding to CD3e (49). In addition, it was
shown that the CD3d/e pair associates with TCR-a,
whereas the CD3g/e pair associates with TCR-b. This as-
sociation takes place upon formation of an intrachain disul-
fide bridge between TCR-a and -b (10). Additional stud-
ies have shown that CD3e and TCR-b pair via their
ectodomains, whereas the association of the other CD3
components with TCR-a and -b is largely mediated by in-
teractions within their transmembrane regions. The prox-
imity of TCR-b and CD3g has been suggested by cross-
linking experiments in humans (50) and mice (7). Based on
these findings, it is likely that the CD3e subunit that is
physically associated with the Cb FG loop is paired with
CD3g and that the second CD3e, which pairs with the ex-
tracellular domain of the CD3d subunit, associates via its
transmembrane domain with the TCR-a (51). The ability
of the CD3e/g dimer–specific mAb 7D6 (52) to partially
inhibit FITC-H57 binding to T cells is also consistent with
this view (data not shown).
An interesting feature of the potential interaction of
CD3e within the TCR C domain module relates to certain
Figure 4. Human CD3e does not alter the affinity of H57 for its
epitope. Splenocytes from WT or hCD3etg mice were triple stained with
the indicated molar concentration of FITC-H57 and with the labeled
anti-CD4 and anti-CD8 with or without preincubation with an unlabeled
competitor mAb (designated after the named mouse strain). The mFI of
FITC-H57 binding to the T cells (CD41 or CD81 cells) was calculated
for each sample as explained in Materials and Methods. Results are given
for CD41 T cells and identical data was observed for CD81 T cells.1534 T Cell Receptor Subunit Topology
critical Ca residues that are preserved in pre-Ta (pTa), a
30-kD glycoprotein whose expression is restricted to early
CD42CD82 DN T lineage cells (53–55). The pre-TCR, a
disulfide-linked heterodimer of a functionally rearranged
TCR-b chain and the pTa chain, noncovalently associated
with the CD3 components is expressed in DN immature
thymocytes (56). During development, the DN to DP thy-
mocyte transition is induced by an as yet unknown ligand
that binds to the pre-TCR, resulting in expression of ma-
ture type a/b TCR heterodimers on DP thymocytes (57–
59). Although there is only 12% identity between pTa and
Ca in humans and mice (60), the Ca residues involving
important polar interactions with the Cb domain are all
conserved in the pTa sequence. Given that conserved
structural elements account for close to half of the pTa–Ca
amino acid sequence identities, it is very obvious that the
heterodimer interface of pTa–Cb will be extremely similar
to that of Ca–Cb. With this in mind and since genetic dis-
ruption of the CD3e gene results in T cell development
blockage at the DN stage, it is likely that the CD3e subunit
is accommodated in the pre-TCR module in a manner
similar to its mode in the mature a/b-TCR.
One can imagine that certain mouse CD3e residues con-
tribute to the contacts made between H57 and the TCR.
In this regard, the total buried molecular surface area at the
N15 TCR-H57 Fab interaction is 1460A2 (720A2 for N15
and 740A2 for H57) (33), consistent with the range of val-
ues observed for other intact protein antigen–Fab interac-
tions (61–63). However, one unusual feature of the N15–
H57 interaction is the predominance of contacts made by
the light chain (430A2 buried surface) rather than the heavy
chain (310A2 buried surface) (33). This unusual characteris-
tic led us to postulate that the mAb H57 heavy chain may
interact primarily with TCR Cb but in addition with some
CD3e residues. In agreement with that notion is the large
rotational mobility (z208) of the Fab relative to the TCR
Cb FG loop observed in the two independent copies of the
TCR–Fab complexes in the asymmetric unit of the crystal
(33). Nevertheless, analysis of the hemizygous hCD3etg
mice revealed that although those T cells contain only half
the surface copy number of the mouse CD3e, H57 affinity
is unaltered. This result suggests that the assembly of the
TCR complex is not affected by the expression of the hu-
man CD3e, and that the extracellular domain of the human
CD3e subunit can fit into the mouse TCR C domain
module cavity (Fig. 3 B). Given that the extracellular do-
main of the mouse and human CD3e share 53% identity in
their amino acid sequence, it is possible that any putative
CD3e residues that interact with the H57 heavy chain are
conserved among mouse and human CD3e.
Although the precise functional role of the FG loop in
Cb is far from clear, it is likely to have an important impact
on signaling and/or TCR assembly and structure. The
unique FG loop is conserved among sequences of mouse,
rat, human, and rabbit TCRs (39). Although absent in
TCRs sequences from some other species, it is replaced by
a potential glycosylated addition site whose glycan may
serve a similar structural function (33). Undoubtedly this
loop influences the mobility and disposition of Vb relative
to Cb domains. Although the minihydrophobic patch of
this loop as resolved from the crystal structure fixes the
overall loop orientation relative to the Vb and Cb do-
mains, local movements are permitted (33). How, if at all,
peptide–MHC interactions might transfer information to
the CD3 signaling subunits by affecting the FG Cb loop
remains to be tested experimentally.
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